Dr. Lawrence P. Menache, MD

Dr. Menache practices at CHRISTUS St. Frances Cabrini Hospital in Alexandria, Louisiana, part of CHRISTUS Health.

Dr. Menache's NPI, 1932176153, was assigned on March 7, 2006. Dr. Menache holds Louisiana license 08338R.

Dr. Menache's primary practice is CHRISTUS St. Frances Cabrini Hospital, at 3330 Masonic Drive, Alexandria, LA 71301 in Rapides Parish. The practice phone is (318) 487-1122.

Dr. Menache's primary practice is CHRISTUS St. Frances Cabrini Hospital in Alexandria, Louisiana, part of CHRISTUS Health. Dr. Menache is also affiliated with Rapides Regional Medical Center. The medical group on file is Alexandria Radiation Oncology. Dmand AI also links Dr. Menache to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Menache practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Menache's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Menache is licensed in Louisiana.

CMS data shows 2,537 Medicare services from Dr. Menache across 17 procedure codes in 2024, for 338 Medicare patients. Medicare paid $221,175 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 338 Medicare patients who saw Dr. Menache in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have cancer, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Menache's median patient age at 70, with 58% women.

In 2024, Dr. Menache wrote 148 Medicare Part D claims for 73 patients. 88% of them were for generic drugs. CMS names the drug for 92 of them, across 5 drugs with 11 or more claims each, at $1,194 in total drug cost. In 2023, CMS named 108 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 44 out of 100 for Dr. Menache for performance year 2024, reported individually. Dr. Menache accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 164 general payments to Dr. Menache from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Merck Sharp & Dohme Corporation paid the most, $407.